BRANDON EAREHART: Open Payments
NPI 1881701472 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 32 payments from 6 companies in 2025. Trend: 2023 $450 · 2024 $335 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $438 |
| ViiV Healthcare Company | 12 | $228 |
| Axsome Therapeutics, Inc. | 2 | $136 |
| Merck Sharp & Dohme LLC | 5 | $125 |
| EMD Serono, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
Products named: APRETUDE, Auvelity, PIFELTRO, Yeztugo, CABENUVA, CAPLYTA.
Industry payments across GA — which companies pay providers there.
